ARIAD PHARMACEUTICALS INC: 10-Q filed 2016-08-08
What ARIAD PHARMACEUTICALS INC reported in its quarterly report filed 2016-08-08 (fiscal Q2 2016): 39 published measures, 115 facts as tagged in accession 0000884731-16-000095.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-08-08
- Fiscal period
- fiscal Q2 2016
- Accession
- 0000884731-16-000095 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARIAD PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 624,367,000 | USD | |
| At 2015-12-31 | 546,692,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 662,256,000 | USD | |
| At 2015-12-31 | 649,833,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -37,889,000 | USD | |
| At 2015-12-31 | -103,141,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 273,047,000 | USD | |
| At 2015-12-31 | 230,888,000 | USD | |
| At 2015-06-30 | 273,966,000 | USD | |
| At 2014-12-31 | 352,688,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 109,848,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 56,061,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -63,160,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -115,835,000 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 68,125,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 103,723,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 29,238,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 53,229,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -1,389,690,000 | USD | |
| At 2015-12-31 | -1,445,751,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 191,485,000 | shares | 91 |
| 2016-01-01 to 2016-06-30 | 190,894,000 | shares | 182 |
| 2015-04-01 to 2015-06-30 | 188,598,000 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 188,220,000 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 194,569,000 | shares | 91 |
| 2016-01-01 to 2016-06-30 | 193,504,000 | shares | 182 |
| 2015-04-01 to 2015-06-30 | 188,598,000 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 188,220,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 0.57 | USD/shares | 91 |
| 2016-01-01 to 2016-06-30 | 0.29 | USD/shares | 182 |
| 2015-04-01 to 2015-06-30 | -0.33 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.62 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 0.56 | USD/shares | 91 |
| 2016-01-01 to 2016-06-30 | 0.29 | USD/shares | 182 |
| 2015-04-01 to 2015-06-30 | -0.33 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.62 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 1,754,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 2,006,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 300,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 514,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 300,962,000 | USD | |
| At 2015-12-31 | 254,082,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 2,658,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 9,377,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 10,644,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 19,078,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -11,663,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -59,525,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -58,611,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -108,309,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 307,120,000 | USD | |
| At 2015-12-31 | 275,197,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 5,401,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 10,348,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 3,813,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 7,668,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 100,663,000 | USD | |
| At 2015-12-31 | 132,284,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 8,111,000 | USD | |
| At 2015-12-31 | 17,013,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 858,000 | USD | |
| At 2015-12-31 | 899,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 14,106,000 | USD | |
| At 2015-12-31 | 15,686,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 79,788,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 163,248,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 87,849,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 161,538,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 903,000 | USD | |
| At 2015-12-31 | 1,096,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 34,242,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 70,219,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 48,622,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 82,172,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 42,864,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 86,943,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 38,739,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 78,183,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 192,121,405 | shares | |
| At 2015-12-31 | 189,662,148 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 1,350,697,000 | USD | |
| At 2015-12-31 | 1,338,585,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 912,000 | USD | |
| At 2016-03-31 | -128,000 | USD | |
| At 2015-12-31 | 3,835,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 345,422,000 | USD | |
| At 2015-12-31 | 296,666,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 44,460,000 | USD | |
| At 2015-12-31 | 42,584,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 6,086,000 | USD | |
| At 2015-12-31 | 11,244,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 22,063,000 | USD | |
| At 2015-12-31 | 22,132,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 111,602,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 58,067,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -62,860,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -115,321,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 110,888,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 53,138,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -63,732,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -116,094,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 1,200,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 2,400,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 800,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 1,700,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 123,265,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 117,592,000 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -4,249,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -7,012,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 7,448,000 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 6,022,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 1,122,000 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 347,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | -6,789,000 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 97,000 | USD | 181 |
Inspect the source
- Entity
- ARIAD PHARMACEUTICALS INC / CIK 0000884731
- Captured
- SEC response SHA-256
b2493b313f782a3557ff97ff9225af4ea590328647a706006f7c22be64ae54b4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000884731.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))